BEDWORTH HEALTH CENTRE — All Prescriptions & Medications
Practice Code: M84011 | BEDWORTH, CV12 8NQ
Over the last 12 months, BEDWORTH HEALTH CENTRE prescribed 598,972 items across 809 different medications at a total cost of £4,585,088 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Doxylamine succinate/pyridoxine hydrochloride | 10 | 240 | £342 | -9.4% ▼ |
| Naratriptan hydrochloride | 10 | 84 | £16 | -61.8% ▼ |
| Tenofovir disoproxil | 10 | 300 | £276 | +61.0% ▲ |
| Miconazole | 10 | 540 | £45 | +214.7% ▲ |
| 10 | 465 | £466 | +129.1% ▲ | |
| 10 | 40 | £5.4K | +59.2% ▲ | |
| 10 | 44 | £131 | -69.5% ▼ | |
| 10 | 24 | £80 | +25.1% ▲ | |
| 10 | 16 | £307 | -1.5% vs avg | |
| 10 | 90 | £260 | +58.5% ▲ | |
| 10 | 120 | £309 | -15.0% ▼ | |
| 10 | 800 | £408 | +76.3% ▲ | |
| 10 | 11 | £818 | +296.6% ▲ | |
| 10 | 22 | £182 | +107.3% ▲ | |
| 10 | 1,700 | £580 | +102.6% ▲ | |
| 10 | 51 | £625 | +119.8% ▲ | |
| 10 | 760 | £218 | -35.1% ▼ | |
| Mebeverine hydrochloride compound preparations | 11 | 506 | £441 | -2.7% ▼ |
| Telmisartan with diuretic | 11 | 308 | £142 | -2.7% ▼ |
| Nicardipine hydrochloride | 11 | 308 | £30 | +9.6% ▲ |
| Riluzole | 11 | 6,600 | £2.2K | +6.0% ▲ |
| Insulin glulisine | 11 | 84 | £476 | -48.7% ▼ |
| Saxagliptin/dapagliflozin | 11 | 308 | £545 | -53.3% ▼ |
| Flavoxate hydrochloride | 11 | 990 | £122 | -6.9% ▼ |
| Powder 3.7 kcal/g energy and protein fortifier (0913081) | 11 | 628 | £1.5K | +76.4% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 11 | 2,700 | £89 | -1.9% vs avg |
| Liquid paraffin | 11 | 4,900 | £53 | +58.6% ▲ |
| Crotamiton | 11 | 1,100 | £62 | -33.8% ▼ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 11 | 1,050 | £129 | +26.8% ▲ |
| Fluorouracil (Sunscreen) | 11 | 440 | £344 | -69.8% ▼ |
| 11 | 105 | £351 | +74.9% ▲ | |
| 11 | 520 | £1.4K | +66.0% ▲ | |
| 11 | 20 | £728 | +142.8% ▲ | |
| 11 | 220 | £107 | +37.2% ▲ | |
| 11 | 660 | £2.3K | -0.3% vs avg | |
| 11 | 660 | £2.3K | +1.1% vs avg | |
| 11 | 330 | £1.6K | +98.9% ▲ | |
| 11 | 570 | £1.8K | +53.1% ▲ | |
| 11 | 509 | £52 | +36.5% ▲ | |
| Clonidine hydrochloride | 12 | 672 | £53 | -34.3% ▼ |
| Perindopril arginine | 12 | 360 | £122 | +1.5% vs avg |
| Olmesartan medoxomil/amlodipine | 12 | 336 | £193 | -9.0% ▼ |
| Valsartan/amlodipine | 12 | 336 | £302 | +9.4% ▲ |
| Gemfibrozil | 12 | 540 | £327 | +18.8% ▲ |
| Glycopyrronium bromide | 12 | 360 | £314 | -67.8% ▼ |
| Reboxetine | 12 | 672 | £203 | -22.1% ▼ |
| Canagliflozin/metformin | 12 | 672 | £418 | -19.9% ▼ |
| Liothyronine sodium | 12 | 1,344 | £5.3K | -43.7% ▼ |
| Metronidazole | 12 | 480 | £49 | +81.5% ▲ |
| Combined ethinylestradiol 35mcg | 12 | 1,638 | £105 | -3.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.